{
  "disease_name": "Argininosuccinic aciduria",
  "orpha_code": "23",
  "drugs": [
    {
      "name": "RAVICTI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/445606?name=23&mode=orpha&region=",
      "regulatory_id": "445606",
      "orpha_substance_code": "ORPHA:247525",
      "details": [
        "RAVICTI(Tradename                        - 27/11/2015)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "RAVICTI(Tradename                        - 27/11/2015)",
        "(Tradename                        - 27/11/2015)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/445605?name=23&mode=orpha&region=&status=all",
          "text": "RAVICTI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90",
          "text": "ORPHA:90 Argininemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247525",
          "text": "ORPHA:247525 Citrullinemia type I",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/445606?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:247525 Citrullinemia type I\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Heterologous human adult liver derived stem cells",
      "substance_url": "/en/drug/substance/102674?name=23&mode=orpha&region=&status=all",
      "substance_id": "102674",
      "regulatory_url": "/en/drug/regulatory/628305?name=23&mode=orpha&region=",
      "regulatory_id": "628305",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 16/03/2022)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 16/03/2022)",
        "(Medicinal product                        - 16/03/2022)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/102674?name=23&mode=orpha&region=&status=all",
          "text": "Heterologous human adult liver derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/628305?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "sodium phenylacetate / sodium benzoate",
      "substance_url": "/en/drug/substance/87861?name=23&mode=orpha&region=&status=all",
      "substance_id": "87861",
      "regulatory_url": "/en/drug/regulatory/563460?name=23&mode=orpha&region=",
      "regulatory_id": "563460",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "sodium phenylacetate / sodium benzoate(Medicinal product                        - 28/06/2019)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "sodium phenylacetate / sodium benzoate(Medicinal product                        - 28/06/2019)",
        "(Medicinal product                        - 28/06/2019)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/87861?name=23&mode=orpha&region=&status=all",
          "text": "sodium phenylacetate / sodium benzoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/563460?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles",
      "substance_url": "/en/drug/substance/500711?name=23&mode=orpha&region=&status=all",
      "substance_id": "500711",
      "regulatory_url": "/en/drug/regulatory/500713?name=23&mode=orpha&region=",
      "regulatory_id": "500713",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles(Medicinal product                        - 12/12/2017)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles(Medicinal product                        - 12/12/2017)",
        "(Medicinal product                        - 12/12/2017)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/500711?name=23&mode=orpha&region=&status=all",
          "text": "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/500713?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium benzoate",
      "substance_url": "/en/drug/substance/83694?name=23&mode=orpha&region=&status=all",
      "substance_id": "83694",
      "regulatory_url": "/en/drug/regulatory/480496?name=23&mode=orpha&region=",
      "regulatory_id": "480496",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Sodium benzoate(Medicinal product                        - 18/11/2016)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Sodium benzoate(Medicinal product                        - 18/11/2016)",
        "(Medicinal product                        - 18/11/2016)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/83694?name=23&mode=orpha&region=&status=all",
          "text": "Sodium benzoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480496?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium benzoate",
      "substance_url": "/en/drug/substance/83694?name=23&mode=orpha&region=&status=all",
      "substance_id": "83694",
      "regulatory_url": "/en/drug/regulatory/449894?name=23&mode=orpha&region=",
      "regulatory_id": "449894",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Sodium benzoate(Medicinal product                        - 11/01/2016)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Sodium benzoate(Medicinal product                        - 11/01/2016)",
        "(Medicinal product                        - 11/01/2016)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/83694?name=23&mode=orpha&region=&status=all",
          "text": "Sodium benzoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/449894?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Heterologous human adult liver-derived progenitor cells",
      "substance_url": "/en/drug/substance/356372?name=23&mode=orpha&region=&status=all",
      "substance_id": "356372",
      "regulatory_url": "/en/drug/regulatory/364067?name=23&mode=orpha&region=",
      "regulatory_id": "364067",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Heterologous human adult liver-derived progenitor cells(Medicinal product                        - 17/07/2013)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Heterologous human adult liver-derived progenitor cells(Medicinal product                        - 17/07/2013)",
        "(Medicinal product                        - 17/07/2013)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/356372?name=23&mode=orpha&region=&status=all",
          "text": "Heterologous human adult liver-derived progenitor cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/364067?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Human heterologous liver cells (for infusion)",
      "substance_url": "/en/drug/substance/90800?name=23&mode=orpha&region=&status=all",
      "substance_id": "90800",
      "regulatory_url": "/en/drug/regulatory/260279?name=23&mode=orpha&region=",
      "regulatory_id": "260279",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Human heterologous liver cells (for infusion)(Medicinal product                        - 17/12/2010)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Human heterologous liver cells (for infusion)(Medicinal product                        - 17/12/2010)",
        "(Medicinal product                        - 17/12/2010)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90800?name=23&mode=orpha&region=&status=all",
          "text": "Human heterologous liver cells (for infusion)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/260279?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Glycerol phenylbutyrate",
      "substance_url": "/en/drug/substance/222387?name=23&mode=orpha&region=&status=all",
      "substance_id": "222387",
      "regulatory_url": "/en/drug/regulatory/238139?name=23&mode=orpha&region=",
      "regulatory_id": "238139",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Glycerol phenylbutyrate(Medicinal product                        - 10/06/2010)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Glycerol phenylbutyrate(Medicinal product                        - 10/06/2010)",
        "(Medicinal product                        - 10/06/2010)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/222387?name=23&mode=orpha&region=&status=all",
          "text": "Glycerol phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/238139?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PHEBURANE",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/628626?name=23&mode=orpha&region=",
      "regulatory_id": "628626",
      "orpha_substance_code": "ORPHA:147",
      "details": [
        "PHEBURANE(Tradename                        - 17/06/2022)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "PHEBURANE(Tradename                        - 17/06/2022)",
        "(Tradename                        - 17/06/2022)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/628534?name=23&mode=orpha&region=&status=all",
          "text": "PHEBURANE",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/628626?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "RAVICTI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/465104?name=23&mode=orpha&region=",
      "regulatory_id": "465104",
      "orpha_substance_code": "ORPHA:247525",
      "details": [
        "RAVICTI(Tradename                        - 01/02/2013)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "RAVICTI(Tradename                        - 01/02/2013)",
        "(Tradename                        - 01/02/2013)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/445605?name=23&mode=orpha&region=&status=all",
          "text": "RAVICTI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90",
          "text": "ORPHA:90 Argininemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247525",
          "text": "ORPHA:247525 Citrullinemia type I",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/465104?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:247525 Citrullinemia type I\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "BUPHENYL",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131075?name=23&mode=orpha&region=",
      "regulatory_id": "131075",
      "orpha_substance_code": "ORPHA:147",
      "details": [
        "BUPHENYL(Tradename                        - 30/04/1996)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "BUPHENYL(Tradename                        - 30/04/1996)",
        "(Tradename                        - 30/04/1996)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/25061?name=23&mode=orpha&region=&status=all",
          "text": "BUPHENYL",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131075?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles",
      "substance_url": "/en/drug/substance/500711?name=23&mode=orpha&region=&status=all",
      "substance_id": "500711",
      "regulatory_url": "/en/drug/regulatory/500717?name=23&mode=orpha&region=",
      "regulatory_id": "500717",
      "orpha_substance_code": "ORPHA:23",
      "details": [
        "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles(Medicinal product                        - 18/09/2017)Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles(Medicinal product                        - 18/09/2017)",
        "(Medicinal product                        - 18/09/2017)",
        "Disease(s) concernedORPHA:23 Argininosuccinic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/500711?name=23&mode=orpha&region=&status=all",
          "text": "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/500717?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Allogeneic adult liver-derived stem cells",
      "substance_url": "/en/drug/substance/629851?name=23&mode=orpha&region=&status=all",
      "substance_id": "629851",
      "regulatory_url": "/en/drug/regulatory/629852?name=23&mode=orpha&region=",
      "regulatory_id": "629852",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Allogeneic adult liver-derived stem cells(Medicinal product                        - 10/08/2022)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Allogeneic adult liver-derived stem cells(Medicinal product                        - 10/08/2022)",
        "(Medicinal product                        - 10/08/2022)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/629851?name=23&mode=orpha&region=&status=all",
          "text": "Allogeneic adult liver-derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/629852?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end",
      "substance_url": "/en/drug/substance/688360?name=23&mode=orpha&region=&status=all",
      "substance_id": "688360",
      "regulatory_url": "/en/drug/regulatory/688517?name=23&mode=orpha&region=",
      "regulatory_id": "688517",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end(Medicinal product                        - 11/09/2024)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end(Medicinal product                        - 11/09/2024)",
        "(Medicinal product                        - 11/09/2024)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/688360?name=23&mode=orpha&region=&status=all",
          "text": "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/688517?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Glycerol phenylbutyrate",
      "substance_url": "/en/drug/substance/222387?name=23&mode=orpha&region=&status=all",
      "substance_id": "222387",
      "regulatory_url": "/en/drug/regulatory/238146?name=23&mode=orpha&region=",
      "regulatory_id": "238146",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Glycerol phenylbutyrate(Medicinal product                        - 27/04/2009)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Glycerol phenylbutyrate(Medicinal product                        - 27/04/2009)",
        "(Medicinal product                        - 27/04/2009)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/222387?name=23&mode=orpha&region=&status=all",
          "text": "Glycerol phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/238146?name=23&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:00:29.395881",
  "run_number": 1,
  "total_drugs_found": 16,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Argininosuccinic+aciduria&orphaCode=23&name=23&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Argininosuccinic aciduria",
    "orphaCode": "23",
    "name": "23",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}